OncoSec Medical to Present at the 12th Annual BIO Investor Forum

OncoSec Medical to Present at the 12th Annual BIO Investor Forum

04 October 2013,   By ,   0 Comments

SAN DIEGO – October 3, 2013 — OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, has announced it will be presenting at the 12th Annual BIO Investor Forum.

Punit Dhillon, President and CEO of OncoSec Medical, will provide a company overview and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

The presentation will take place on Tuesday, October 8 at 2:30 p.m. PT in the Presidio room at the Palace Hotel in San Francisco, California. The presentation will also be webcast and can be viewed at this link: http://www.veracast.com/webcasts/bio/investorforum2013/79210379405.cfm

A webcast replay will be available one hour after the conclusion of the live event and will expire on January 7, 2014.

About the BIO Investor Forum

The BIO Investor Forum is a national investor event to explore investment trends and opportunities in life sciences, with a focus on venture-stage growth and emerging public companies as well as those poised to join the growth “watch list” in 2014. The conference delivers a rich program that features corporate presentations and panel debates on the “sweet spots” and growth challenges facing the industry.

 


Real Time Web Analytics